---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/42338400.md"
description: "$Creative Medical Tech(CELZ.US) surged +79% today, as the FDA cleared the expansion of the Phase 2 ADAPT trial for CELZ-201 targeting chronic low back pain, adding a low-opioid cohort with enrollment already over 85%; meanwhile, the company completed a $4.5 million warrant exercise financing. The story and numbers are fresh, but last quarter's revenue was only $6,000 with a net loss of $1.4 million, a typical small-cap biotech pulse. Whether it can hold up depends on the progress of subsequent Phase 3 negotiations.$Ambarella(AMBA.US) rose over 28%, as Rosenblatt listed it as a key target in the physical AI theme for the second half of the year, and KeyBanc is also running institutional roadshows with management this week; the company's Edge AI revenue already accounts for 80% of total revenue, with over 42 million system-on-chip units shipped. This shift in analyst consensus is more noteworthy than the price movement itself.$Hesai(HSAI.US) also rose over 15%, as the shareholder meeting just approved a 8-for-1 reverse stock split plan, plus a potential issuance of up to 10% new shares, expanding both liquidity and the pool of potential investors; combined with a new Outperform rating (target price $23.5) and sentiment from the Mercedes-Benz LiDAR partnership, the reverse split itself doesn't change the fundamentals but indeed acts as an amplifier for short-term capital attention."
datetime: "2026-07-01T10:41:16.000Z"
locales:
  - [en](https://longbridge.com/en/topics/42338400.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/42338400.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/42338400.md)
author: "[本职喵星人](https://longbridge.com/en/profiles/27713076.md)"
---

# $Creative Medical Tech(CELZ.US) surged +79% today,…


### Related Stocks

- [CELZ.US](https://longbridge.com/en/quote/CELZ.US.md)
- [HSAI.US](https://longbridge.com/en/quote/HSAI.US.md)
- [AMBA.US](https://longbridge.com/en/quote/AMBA.US.md)
- [MBGYY.US](https://longbridge.com/en/quote/MBGYY.US.md)
- [02525.HK](https://longbridge.com/en/quote/02525.HK.md)